(c) 2024 PillSync.com

Levothyroxine sodium Levothyroxine Sodium 0.075 MG Oral Tablet

1 INDICATIONS AND USAGE Hypothyroidism Levothyroxine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use: • Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium tablets may induce hyperthyroidism [see Warnings and Precautions (5.4)]. • Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. Levothyroxine sodium tablets is L-thyroxine (T4) indicated for: • Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. (1) • Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. (1) Limitations of Use: - not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. - Not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.

Sandoz Inc.


8 years ago OVAL PURPLE 75 GG 333 Levothyroxine sodium  Levothyroxine Sodium 0.075 MG Oral Tablet

OVAL PURPLE 75 GG 333

8 years ago OVAL PURPLE 75 GG 333 Levothyroxine sodium  Levothyroxine Sodium 0.075 MG Oral Tablet

75 GG 333 OVAL PURPLE

16 HOW SUPPLIED/STORAGE AND HANDLING Levothyroxine Sodium Tablets, USP are supplied as follows: Strength (mcg) Color/Shape Tablet Markings NDC# for bottles of 90 NDC # for bottles of 1000 25 orange/Caplet “25†and “GG/331†0781-5180-92 0781-5180-10 50 white/ Caplet “50†and “GG/332†0781-5181-92 0781-5181-10 75 violet/ Caplet “75†and “GG/333†0781-5182-92 0781-5182-10 88 olive green/ Caplet “88†and ‘GG/334†0781-5183-92 0781-5183-10 100 yellow/ Caplet “100†and “GG/335†0781-5184-92 0781-5184-10 112 Rose/ Caplet “112†and “GG/336†0781-5185-92 0781-5185-10 125 brown/ Caplet “125†and “GG/337†0781-5186-92 0781-5186-10 137 turquoise/ Caplet “137†and “GG/330†0781-5191-92 0781-5191-10 150 blue/ Caplet “150†and “GG/338†0781-5187-92 0781-5187-10 175 lilac/ Caplet “175†and “GG/339†0781-5188-92 0781-5188-10 200 pink/ Caplet “200†and “GG/340†0781-5189-92 0781-5189-10 300 green/ Caplet “300†and “GG/341†0781-5190-92 0781-5190-10 Storage Conditions Store at 25°C (77°F); excursions permitted to 15° to 30° C (59° to 86° F) [see USP Controlled Room Temperature]. Levothyroxine sodium tablets should be protected from light and moisture.


More pills like OVAL 75 GG 333












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site